Adult Disease Clinical Trial
Official title:
Applying a Stress Framework to Health Behavior Change: A Fitbit Study
Verified date | April 2017 |
Source | Brandeis University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The current study aims to counteract perceived stress-related barriers to implementation and
maintenance of positive health behavior change (i.e., increasing physical activity), by
providing an individually tailored and comprehensive informational support program. This
translates into an intervention that, in addition to behavior monitoring (low informational
support), will provide comprehensive informational support by combining advice and
suggestions on how to achieve positive physical activity change with information on the
health effects of such a change (high informational support). The latter will be achieved by
providing information on general health benefits of increasing physical activity as well as
on how physical activity change is linked to individual changes in health-relevant outcomes
(i.e., mood and sleep quality changes). Specifically, it is hypothesized that:
- Higher chronic stress levels in general as well as stress perceived by the anticipated
task of improving physical activity will be negatively associated with physical
activity changes.
- Participants receiving informational support will show decreases in task-related
stress.
- Furthermore, participants who receive comprehensive informational support will show
larger physical activity improvements than participants who do not receive
informational support.
- Initial stress will act as a moderator of the effects of informational support on
physical activity, such that higher initial stress will reduce the positive effects of
informational support.
Importantly, the proposed intervention is specifically designed to support the subsequent
development of an intervention program that is not only feasible, but easy to implement by
individuals motivated to achieve a positive health behavior change. A key factor will be the
insights gained into stress as a mechanism that counteracts implementation and maintenance
of behavior change. This is especially important given the central role of stress in
negative health outcomes associated with lack of physical activity, such as poor sleep,
negative mood, and chronic low-grade inflammation.
Status | Completed |
Enrollment | 104 |
Est. completion date | January 2017 |
Est. primary completion date | January 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 75 Years |
Eligibility |
Inclusion Criteria: - residents of Waltham and surrounding communities - between the ages of 50 and 70+ - English and non-English speaking participants - individuals who are sedentary and/or dealing with health issues and have been unsuccessful in implementing behavior change **We will ask participants three questions that will be rated on a 1 to 10 scale. They will be asked 1) how concerned they are about their current level of exercise, 2) how much pressure they feel to exercise more, and 3) how difficult it feels to overcome obstacles to exercise. To be eligible, participants must rate the first question at a 6 or higher and the three questions together at 15. Exclusion Criteria: - Participants who have been told not to participate in physical activity or who have doubts about their ability to safely increase physical activity - not able to walk or not able to walk continuously for several minutes without pain - being very active and rate the question regarding how much they are in motion during the day at 8 or higher (on a scale of 1-10) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Brandeis University | National Institute on Aging (NIA) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | daily steps | daily physical activity measured in steps taken | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Completed |
NCT02309164 -
The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).
|
N/A | |
Unknown status |
NCT01614353 -
Medication-taking Preferences & Practices of Patients With Chronic Conditions
|
N/A | |
Completed |
NCT01345981 -
A Comparison of Pain Severity on Injection of MCT/LCT Propofol Between Lidocaine 20 mg, 40 mg, and Without Lidocaine.
|
N/A | |
Recruiting |
NCT05817734 -
Human Phenotype Project Study Protocol
|
||
Recruiting |
NCT06403436 -
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT04291417 -
Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Baylor S&W
|
||
Recruiting |
NCT04643015 -
New Ways of Doing Magnetic Resonance Imaging in Children and Adults
|
||
Active, not recruiting |
NCT03986879 -
Relationship of the Physical Activity Practice and Its Different Domains With Cardiac Autonomic Modulation
|
||
Recruiting |
NCT04855929 -
A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients With Advanced Cancer.
|
Phase 1 | |
Completed |
NCT01346384 -
Time - Related Cuff Pressure and Volume of the Laryngeal Tube With the Use of Nitrous Oxide
|
N/A | |
Completed |
NCT03535441 -
HMGB1 Release From Hemorrhagic Shock Patients
|
||
Completed |
NCT04819035 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - Indiana University Hospital
|
||
Completed |
NCT04958499 -
Effectiveness of Bio-Healthy Park on Adult
|
N/A | |
Recruiting |
NCT06007092 -
Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT04353388 -
Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University
|
||
Terminated |
NCT04276714 -
Revofitâ„¢ System Evaluation on Residual Limb Pain in Amputee Patients
|
N/A | |
Terminated |
NCT05641324 -
A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
|
Phase 1 | |
Recruiting |
NCT05578872 -
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).
|
Phase 1/Phase 2 | |
Suspended |
NCT03172897 -
Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients
|
Phase 4 |